MFG-E8 Is Critical for Embryonic Stem Cell-Mediated T Cell Immunomodulation.
MFG-E8 Is Critical for Embryonic Stem Cell-Mediated T Cell Immunomodulation.
复制标题
DOI:
10.1016/j.stemcr.2015.09.005
复制
发表时间:
2015-11-10
影响因子:
5.9
通讯作者:
Wang L
中科院分区:
文献类型:
--
作者:
Tan Y;AlKhamees B;Jia D;Li L;Couture JF;Figeys D;Jinushi M;Wang L
The molecules and mechanisms pertinent to the low immunogenicity of undifferentiated embryonic stem cells (ESCs) remain poorly understood. Here, we provide evidence that milk fat globule epidermal growth factor 8 (MFG-E8) is a vital mediator in this phenomenon and directly suppresses T cell immune responses. MFG-E8 is enriched in undifferentiated ESCs but diminished in differentiated ESCs. Upregulation of MFG-E8 in ESCs increases the successful engraftment of both undifferentiated and differentiated ESCs across major histocompatibility complex barriers. MFG-E8 suppresses T cell activation/proliferation and inhibits Th1, Th2, and Th17 subpopulations while increasing regulatory T cell subsets. Neutralizing MFG-E8 substantially abrogates these effects, whereas addition of recombinant MFG-E8 to differentiated ESCs restores immunosuppression. Furthermore, we provide the evidence that MFG-E8 suppresses T cell activation and regulates T cell polarization by inhibiting PKCθ phosphorylation through the α3/5βV integrin receptor. Our findings offer an approach to facilitate transplantation acceptance. MFG-E8 is enriched in undifferentiated but diminished in differentiated ESCs MFG-E8 promotes allogeneic engraftment of ESC-derived tissues across the MHC barrier ESC-produced MFG-E8 inhibits Th1/Th2/Th17 while promoting regulatory T cells MFG-E8 modulates T cell polarization via inhibiting PKCθ phosphorylation Milk fat globule epidermal growth factor 8 (MFG-E8) is originally identified in mammary gland epithelial cells. Wang, Jinushi, and colleagues find that MFG-E8 is enriched in undifferentiated ESCs and modulates T cell responses via inhibition of PKCθ phosphorylation. Upregulation of MFG-E8 promotes successful engraftment of non-self ESCs and their derivatives across the MHC barrier.